tiprankstipranks
Intensity Therapeutics, Inc. (INTS)
NASDAQ:INTS
US Market
Want to see INTS full AI Analyst Report?

Compare Intensity Therapeutics, Inc. (INTS) vs. Competitors

252 Followers

Comparison Results

Name
Price
Market Cap
P/E Ratio
Yearly Gain
Analyst Consensus
Analyst Price Target
Compare
Top Analysts' Price Target
Smart Score
Follow
Intensity Therapeutics, Inc.
$4.45
$12.93M
-0.82
-46.93%
1 Buy
0 Hold
0 Sell
Moderate Buy
Cellectar Biosciences
$2.41
$24.58M
-0.57
-41.18%
3 Buy
0 Hold
0 Sell
Strong Buy
PDS Biotechnology
$0.68
$12.91M
-0.36
-80.83%
1 Buy
0 Hold
0 Sell
Moderate Buy
GT Biopharma
$0.32
$13.12M
-0.07
-79.59%
Celularity
$0.75
$20.14M
-0.19
-79.91%
Senti Biosciences
$0.40
$13.98M
-0.25
-70.65%

Performance Comparison

Ticker
Company Name
Price
Change
% Change
INTS
Intensity Therapeutics, Inc.
3.96
-3.64
-47.89%
CLRB
Cellectar Biosciences
2.60
-2.10
-44.68%
PDSB
PDS Biotechnology
0.23
-1.01
-81.45%
GTBP
GT Biopharma
0.30
-1.19
-80.07%
CELU
Celularity
0.70
-3.46
-83.25%
SNTI
Senti Biosciences
0.45
-1.15
-71.94%
Compare key indicators and discover each stock’s average analyst price target, as well as the latest recommendations by top Wall Street experts